Observational Study of Survival Outcomes of Stage IV Cancer Patients

Cure Cancer Worldwide Corporation120 enrolled

Overview

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Stage IV Cancer (Solid Tumors Only)Survival

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Presenting with Stage IV cancer (solid tumors only) Exclusion Criteria: * Patient declines inclusion

Locations (1)

Yang Ling Demonstration Zone Hospital

Yangling, Shaanxi, China

Outcomes

Primary Outcomes

survival

Time frame: months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36, 48, 60

Central Contacts

gary smith

CONTACT

5207492035 garylsmith2@msn.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.